-transparent.png){kind=logo}
Sickle-cell disease is usually complicated by vaso-occlusive attacks. A review of the case-histories of 26 patients permitted an analysis of 92 severe attacks. We compared the outcome of 52 attacks treated with hyperhydration associated with a modifying erythrocyte membrane agent (pentoxifylline), with 40 attacks treated with hyperhydration and other drugs. This result compares well the current knowledge of the rheologic mechanisms involved in vaso-occlusive attacks of sickle-cell disease.
Related Publications
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
June 1991,
BMJ (Clinical research ed.),
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
January 1986,
Journal of medicine,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
January 2022,
Proceedings (Baylor University. Medical Center),
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
January 2017,
Nursing,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
November 2021,
Blood reviews,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
July 2002,
Chest,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
November 2020,
Drugs of today (Barcelona, Spain : 1998),
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
June 2017,
Pediatric blood & cancer,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
November 2013,
World journal of clinical pediatrics,
M Clerc, and
D Doh-Egueli, and
F Chapuis, and
A Durin, and
Y Bertrand, and
G Souillet, and
N Philippe
October 1987,
The American journal of the medical sciences,
